Cardiome Pharma Corp.
6190 Agronomy Road
6th Floor
Vancouver,
BC V6T 1Z3
Canada - Map
Phone: 604-677-6905
Fax: 604-677-6915
Web Site: http://www.cardiome.com
| Cardiome Pharma Corp., a life sciences company, focuses on developing drugs to treat or prevent cardiovascular diseases. Its product Vernakalant (iv), which has completed Phase III (ACT 4) and in Phase III (European Comparator) trial is used for the treatment of atrial fibrillation; Vernakalant (oral) that has completed Phase IIa Pilot and Phase IIb study is used for atrial fibrillation; GED-aPC, an ongoing Phase I study product for multiple disease states; and Artesian Programs, which is in pre-clinical studies to attenuate the deleterious effects of the excessive neurohormonal activation that occurs in diseases of cardiac dysfunction. The company was formerly known as Nortran Pharmaceuticals, Inc. and changed its name to Cardiome Pharma Corp. in 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert W. Rieder M.B.A., 61
Exec. Chairman |
N/A
| N/A | Mr. Douglas G. Janzen , 40
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Curtis M. Sikorsky CA,
Chief Financial Officer |
N/A
| N/A | Dr. Donald A. McAfee Ph.D., 67
Chief Scientific Officer |
N/A
| N/A | Dr. Charles J. Fisher Jr., M.D., 62
Consultant |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.17% Nasdaq 
0.06%
Profile
